Loading...
Loading...
India's piperacillin imports from NETHERLANDS total $3.4K across 4 shipments from 1 foreign suppliers. NEUNCO PHARMACEUTICAL BV leads with $3.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ASTRAL STERITECH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for piperacillin โ a concentrated sourcing relationship with select suppliers from NETHERLANDS.

NEUNCO PHARMACEUTICAL BV is the leading Piperacillin supplier from NETHERLANDS to India, with import value of $3.4K across 4 shipments. The top 5 suppliers โ NEUNCO PHARMACEUTICAL BV โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEUNCO PHARMACEUTICAL BV | $3.4K | 4 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ASTRAL STERITECH PRIVATE LIMITED | $3.4K | 4 | 100.0% |
NETHERLANDS โ India trade corridor intelligence
As of April 2026, the Netherlands to India trade corridor for finished pharmaceutical formulations is operating efficiently. Major ports like Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra are handling shipments without significant congestion. Freight rates have stabilized, and the exchange rate between the Indian Rupee (INR) and the Euro remains favorable for trade. These factors contribute to a smooth and cost-effective import process for finished Piperacillin formulations.
The Production Linked Incentive (PLI) scheme and other import substitution policies have been implemented to encourage domestic manufacturing and reduce dependency on imports. While these initiatives aim to boost local production, they may impact the volume of finished pharmaceutical formulation imports from the Netherlands. However, the need for specialized formulations and high-quality products ensures that imports continue to play a role in the Indian pharmaceutical market.
India and the Netherlands share a robust trade relationship, with ongoing discussions to enhance pharmaceutical trade. Negotiations for Free Trade Agreements (FTAs) and mutual recognition of Good Manufacturing Practices (GMP) are underway to facilitate smoother trade flows. These efforts aim to strengthen bilateral ties and ensure the availability of high-quality pharmaceutical products in both markets.
The landed cost of importing finished Piperacillin formulations from the Netherlands to India includes the following components:
These costs are subject to change based on fluctuations in freight rates, exchange rates, and any changes in duty structures.
CDSCO registration, import licensing, and quality testing requirements
Importing finished pharmaceutical formulations containing Piperacillin into India requires compliance with the Drugs and Cosmetics Act, 1940, and associated rules. The Central Drugs Standard Control Organization (CDSCO) mandates that both the foreign manufacturer and the Indian importer obtain necessary registrations and licenses. The foreign manufacturer must possess a valid manufacturing or wholesale drug license in their country. The Indian importer must obtain an Import Registration Certificate and an Import License from CDSCO. The application process involves submitting detailed product information, manufacturing details, and quality control data. The timeline for obtaining these approvals can vary but typically ranges from 3 to 6 months, depending on the completeness of the application and regulatory workload. Specific requirements for Piperacillin formulations under HS Code 30041090 include detailed product dossiers, stability data, and evidence of Good Manufacturing Practice (GMP) compliance.
Imported finished pharmaceutical formulations containing Piperacillin must undergo quality testing to ensure they meet Indian standards. CDSCO-approved laboratories conduct batch-wise testing, which includes verifying the Certificate of Analysis (CoA) provided by the manufacturer. Stability data, particularly for ICH Zone IV conditions, is required to demonstrate the product's shelf-life under Indian climatic conditions. The product must comply with the Indian Pharmacopoeia standards or demonstrate equivalence. Upon arrival, customs drug inspectors perform port inspections to verify the authenticity and quality of the shipments. The inspection process can take several days, and if a batch fails to meet the required standards, it may be rejected, leading to delays or the need for re-exportation.
Between 2024 and 2026, India has implemented several regulatory updates affecting the import of finished pharmaceutical formulations. The introduction of the Production Linked Incentive (PLI) scheme has incentivized domestic manufacturing, potentially impacting the volume of imports. Additionally, bilateral agreements with the Netherlands have streamlined import procedures, reducing approval times and facilitating smoother trade. These changes aim to balance the promotion of domestic industry with the need for high-quality imported pharmaceuticals.
Market demand, customs duty structure, and competitive landscape ยท Import duty: 10%
India imports finished Piperacillin formulations to meet the demand for patented or branded products not manufactured domestically, as well as specific dosage forms required for patient care. The domestic capacity for producing certain Piperacillin formulations is limited, leading to a dependency on imports to fulfill market needs. The market size for Piperacillin formulations in India is substantial, with imports contributing significantly to the availability of these essential medicines.
The import duty structure for finished pharmaceutical formulations under HS Code 30041090 includes a Basic Customs Duty (BCD) of 10%, a Social Welfare Surcharge (SWS) of 10%, and an Integrated Goods and Services Tax (IGST) of 12%. These duties are calculated on the Cost, Insurance, and Freight (CIF) value of the goods. Anti-dumping duties may also apply if the government determines that imports are being sold at unfairly low prices. Exemptions or reductions in duties can occur under specific Free Trade Agreements (FTAs) or government notifications. The total landed duty percentage can vary based on these factors and is subject to change with new regulations.
India sources finished Piperacillin formulations from the Netherlands due to the country's strong pharmaceutical manufacturing capabilities, adherence to international quality standards, and the availability of specialized dosage forms. The Netherlands offers competitive advantages such as patented formulations and high-quality products that may not be available from other suppliers. Other countries, including China, Germany, and the United States, also supply Piperacillin formulations to India, but the Netherlands maintains a competitive position due to its established trade relations and consistent product quality.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports finished Piperacillin formulations from the Netherlands due to the availability of patented formulations, specialized dosage forms, and high-quality products that may not be manufactured domestically. The Netherlands's adherence to international quality standards and its established trade relations with India make it a preferred source for these formulations.
When compared to other origins such as China, Germany, and the United States, the Netherlands offers competitive advantages in terms of product quality, regulatory compliance, and reliability. While other countries may offer lower prices, the Netherlands's consistent quality and adherence to international standards provide a unique advantage for Indian importers seeking reliable sources for finished Piperacillin formulations.
Indian importers face several supply chain risks when sourcing finished Piperacillin formulations from the Netherlands, including single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. To mitigate these risks, importers should consider diversifying their supplier base, monitoring currency exchange rates, staying updated on regulatory changes, and maintaining robust quality assurance processes.
Import license checklist, document requirements, quality testing, and compliance
1. DGFT Importer Exporter Code (IEC): Obtain an IEC from the Directorate General of Foreign Trade.
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Piperacillin suppliers from NETHERLANDS to India include NEUNCO PHARMACEUTICAL BV. The leading supplier is NEUNCO PHARMACEUTICAL BV with import value of $3.4K USD across 4 shipments. India imported Piperacillin worth $3.4K USD from NETHERLANDS in total across 4 shipments.
India imported Piperacillin worth $3.4K USD from NETHERLANDS across 4 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Piperacillin sourced from NETHERLANDS include ASTRAL STERITECH PRIVATE LIMITED. The largest buyer is ASTRAL STERITECH PRIVATE LIMITED with $3.4K in imports across 4 shipments.
The total value of Piperacillin imports from NETHERLANDS to India is $3.4K USD, across 4 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists